台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    90.3
  • 漲跌
    ▲0.4
  • 漲幅
    +0.44%
  • 成交量
    308
  • 產業
    上櫃 生技醫療類股
  • 310人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智擎 (4162)籌碼相關-康和-嘉義 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0805/1805/2803/2004/0104/1404/2405/0605/30708090100110Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

康和-嘉義 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/26292.1000.0091.1021,1060.18%
2025/05/211192.9300.0092.20111,1740.94%
2025/05/201692.99393.1092.40131,1821.10%
2025/05/1900.00992.4091.40-91,189-0.76%
2025/05/16991.3900.0090.9091,2090.74%
2025/05/1400.003091.3891.60-301,258-2.38%
2025/05/121090.4900.0090.60101,2980.77%
2025/05/09289.7000.0090.5021,3770.15%
2025/05/081889.5900.0089.60181,4151.27%
2025/04/3000.00190.2089.20-11,796-0.06%
2025/04/29191.0000.0091.0011,7910.06%
2025/04/2800.00989.7090.50-91,790-0.50%
2025/04/25988.9200.0087.9091,7790.51%
2025/04/1600.00887.8087.10-81,817-0.44%
2025/04/15888.8000.0089.2081,8280.44%
2025/04/0900.00576.2076.50-51,844-0.27%
2025/04/087.181.58382.0084.604.11,8010.23%
2025/04/070.289.0000.0089.000.21,7660.01%
2025/04/022598.9400.0098.80251,7701.41%
2025/04/01197.20298.2097.30-11,773-0.06%
2025/03/310.596.8600.0096.200.51,7710.03%
2025/03/280.1100.0000.00100.500.11,7520.01%
2025/03/261.3104.6500.00104.501.31,7230.08%
2025/03/241105.5000.00105.5011,7140.06%
2025/03/2100.001107.50106.50-11,714-0.06%
2025/03/192105.751107.50104.5011,7180.06%
2025/03/1800.001106.00106.50-11,713-0.06%
2025/03/171.1105.9500.00105.001.11,7140.06%
2025/03/141104.001104.00105.0001,7130.00%
2025/03/133.9104.9800.00103.503.91,7070.23%
2025/03/124107.503107.50107.0011,6950.06%
2025/03/111105.5000.00107.0011,6970.06%
2025/03/102.1106.441107.00107.001.11,6860.06%
2025/03/073.7107.823107.50107.500.71,6650.04%
2025/03/061111.9000.00111.0011,6470.06%
2025/03/052116.501115.50115.5011,6450.06%
2025/03/042.2111.771114.00114.501.21,6340.07%
2025/03/035.1113.009112.61112.50-3.91,620-0.24%
2025/02/271110.5000.00109.0011,5680.06%
2025/02/265116.602117.25115.5031,5530.19%
2025/02/210.1112.7500.00113.000.11,4120.01%
2025/02/200.2110.2100.00110.000.21,3890.01%
2025/02/1900.005110.00110.00-51,396-0.36%
2025/02/181.2110.0400.00110.001.21,4010.08%
2025/02/171.1112.481112.50112.500.11,3970.00%
2025/02/136110.5800.00111.5061,4130.42%
2025/02/121111.004112.00112.00-31,408-0.21%
2025/02/1110.3111.2400.00109.0010.31,3920.74%
2025/02/103.2118.4800.00118.503.21,3370.24%
2025/02/0700.006118.17120.50-61,351-0.44%
2025/02/0611119.273120.50119.0081,3290.60%
2025/02/0500.007112.14113.00-71,194-0.59%
2025/02/0400.005101.00103.00-51,201-0.42%
2025/01/14296.45296.1096.1001,3720.00%
2025/01/10296.00297.1097.0001,3550.00%
2025/01/081103.001103.00103.0001,2990.00%
2025/01/0600.0010101.00101.50-101,259-0.79%
2024/11/27196.0000.0094.1011,0950.09%
2024/11/18498.6000.0096.5041,0100.40%
2024/11/1300.002106.00106.50-2946-0.21%
2024/11/081103.0000.00103.0018730.11%
2024/11/0600.003108.00102.50-3826-0.36%
2024/11/0500.002103.75106.00-2782-0.26%
2024/11/0126104.3849104.17105.00-23730-3.15%
2024/10/3022101.820.1101.50102.0021.96173.54%
2024/10/25098.60198.4097.40-1513-0.19%
2024/10/24199.00197.5098.3004940.00%
2024/10/2300.00194.2093.70-1424-0.24%
2024/10/22186.8000.0086.7014040.25%
2024/09/25088.4000.0088.2006090.00%
2024/09/2000.00188.5087.40-1644-0.16%
2024/09/11082.4000.0082.1006560.00%
2024/09/04182.2000.0082.0016980.14%
2024/08/14083.9000.0083.6007550.00%
2024/07/231094.2000.0094.50107201.39%
2024/07/2200.00792.5992.00-7718-0.97%
2024/07/19195.2000.0094.2017080.14%
2024/07/1800.00198.6099.40-1676-0.15%
2024/07/16097.2000.0097.0006580.00%
2024/07/15398.4000.0098.4036630.45%
2024/07/12096.0000.0095.6006480.00%
2024/07/09196.9000.0096.3016680.15%
2024/07/083100.5000.00100.5036550.46%
2024/07/0300.00197.5096.70-1628-0.16%
2024/07/01099.9000.00101.0006100.00%
2024/06/27196.0000.0095.7015820.17%
2024/06/21094.3000.0093.7006070.00%
2024/06/0500.00291.0092.90-2632-0.32%
2024/06/0400.00890.9090.80-8647-1.24%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章